New Hepatitis B Vaccine Guidelines for Newborns in the U.S.

New Hepatitis B Vaccine Guidelines for Newborns in the U.S.

A federal vaccine advisory committee made a significant decision to change the longstanding recommendation for all U.S. babies to receive the hepatitis B vaccine on the day of their birth. The government has traditionally advised this immediate vaccination to prevent the liver infection. However, the committee voted to recommend the birth dose only for babies born to mothers who test positive for the infection or have an unknown infection status. The decision to administer the birth dose will now be left to the discretion of parents and their healthcare providers.

For babies who do not receive the birth dose, the recommendation is to start hepatitis B vaccinations no earlier than 2 months of age. Some committee members highlighted that most babies are at low risk of infection, and previous studies on potential vaccine harms were limited in scope. Despite concerns raised by medical and doctor groups, the committee's decision may lead to more children being infected with hepatitis B.

The acting director of the Centers for Disease Control and Prevention, Jim O'Neill, will ultimately determine whether to accept the committee's recommendation. This change in the vaccination guidelines for newborns reflects a shift in approach to hepatitis B prevention in the United States.